Literature DB >> 24996611

Left ventricular assist device management and complications.

Edo Y Birati1, J Eduardo Rame2.   

Abstract

Patients on long-term left ventricular assist device (LVAD) support present unique challenges in the intensive care unit. It is crucial to know the status of end-organ perfusion, which may require invasive hemodynamic monitoring with a systemic arterial and pulmonary artery catheter. Depending on the indication for LVAD support (bridge to decision or cardiac transplantation vs destination therapy), it is important to readdress goals of care with the patient (if possible) and their family after major events have occurred that challenge the survival of the patient.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Heart failure; Left ventricular assist device; Post-LVAD

Mesh:

Year:  2014        PMID: 24996611     DOI: 10.1016/j.ccc.2014.04.001

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  13 in total

1.  Shock Management for Cardio-surgical Intensive Care Unit Patient: The Silver Days.

Authors:  Till Hauffe; Bernard Krüger; Dominique Bettex; Alain Rudiger
Journal:  Card Fail Rev       Date:  2016-05

2.  Left Ventricular Assist Devices in the Management of Heart Failure.

Authors:  Edo Y Birati; Mariell Jessup
Journal:  Card Fail Rev       Date:  2015-04

Review 3.  Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support.

Authors:  Thomas C Hanff; Edo Y Birati
Journal:  Curr Heart Fail Rep       Date:  2019-10

4.  Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.

Authors:  Corey E Tabit; Mitchell J Coplan; Phetcharat Chen; Valluvan Jeevanandam; Nir Uriel; James K Liao
Journal:  J Heart Lung Transplant       Date:  2017-06-08       Impact factor: 10.247

Review 5.  [Recommendations for emergency management of patients with permanent mechanical circulatory support : Consensus statement of DGTHG, DIVI, DGIIN, DGAI, DGINA, DGfK and DGK].

Authors:  Kevin Pilarczyk; Udo Boeken; Andreas Beckmann; Andreas Markewitz; P Christian Schulze; Martin Pin; Ingo Gräff; Sebastian Schmidt; Birk Runge; Hans-Jörg Busch; Michael R Preusch; Nils Haake; Gereon Schälte; Jan Gummert; Guido Michels
Journal:  Anaesthesist       Date:  2020-04       Impact factor: 1.041

6.  Oncostatin M: a Potential Biomarker to Predict Infection in Patients with Left Ventricular Assist Devices.

Authors:  Hendra Setiadi; Ahmed M El-Banayosy; Susan George; David W Schmidtke; Aly El-Banayosy; Douglas A Horstmanshof; James W Long
Journal:  ASAIO J       Date:  2021-11-10       Impact factor: 3.826

Review 7.  Mechanical Circulatory Support for the Failing Heart: Continuous-Flow Left Ventricular Assist Devices.

Authors:  Joseph A R Englert; Jennifer A Davis; Selim R Krim
Journal:  Ochsner J       Date:  2016

8.  Patients' decision making process and expectations of a left ventricular assist device pre and post implantation.

Authors:  Lisa A Kitko; Judith E Hupcey; Barbara Birriel; Windy Alonso
Journal:  Heart Lung       Date:  2015-12-29       Impact factor: 2.210

9.  Right Ventricular Global Longitudinal Strain as a Predictor of Acute and Early Right Heart Failure Post Left Ventricular Assist Device Implantation.

Authors:  Lusha W Liang; Alisha Jamil; Jeremy A Mazurek; Kimberly A Urgo; Joyce Wald; Edo Y Birati; Yuchi Han
Journal:  ASAIO J       Date:  2022-03-01       Impact factor: 3.826

Review 10.  Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac Death.

Authors:  Stefano Toldo; Mohammed Quader; Fadi N Salloum; Eleonora Mezzaroma; Antonio Abbate
Journal:  Int J Mol Sci       Date:  2016-06-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.